We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





AACC 2021 to Offer Pathways Highlighting Significance of AI, Emerging Diagnostics and COVID-19 in Clinical Laboratory Medicine

By LabMedica International staff writers
Posted on 31 Aug 2021
The 2021 American Association for Clinical Chemistry (AACC; Washington, DC, USA) Annual Scientific Meeting & Clinical Lab Expo will offer six pathways highlighting different dynamic areas of clinical laboratory medicine.

The six pathways include Data Analytics and AI, Emerging Diagnostics, Laboratory Leadership and Stewardship, COVID-19: Lessons, Transitions, and Data, Population Health and Equity, and Molecular Medicine Pathway.

The Data Analytics and Artificial Intelligence (AI) pathway will comprise various sessions spread across four days. More...
The development of AI and machine learning (ML)-based technologies in medicine and pathology is advancing rapidly, but real-world clinical laboratory implementation has not yet become a reality. One of the scientific sessions will cover how AI and ML will help with patient diagnosis and their application to autoimmune testing. This session will review some of the major breakthroughs in AI/ML and provide example applications. Another scientific session will use an interactive, case-based approach to provide an intuitive overview of ML and its applications to laboratory medicine.

The Emerging Diagnostics pathway will feature scientific sessions on new technologies and innovations to improve the clinical laboratory. One of the sessions will discuss the benefits that new technologies would bring such as the use of 3D printing to alleviate shortages of laboratory supplies. Another subject of discussion will be sample transportation, handling, and processing. The session will discuss how drones could be part of the landscape to facilitate transportation from remote locations and those in high traffic areas, and to coordinate transportation within major organizations that have several locations.

The Laboratory Leadership and Stewardship pathway will feature session experts who will define opportunities for decentralized testing, including those within point-of-care testing and point-of-need testing, analyze requests for decentralized testing to determine if they are suitable and safe for implementation, and compare benefits and challenges of decentralized testing to determine if it will improve the overall care of the patient.

For those interested in interested in learning more about COVID-19 transitions, lessons, and data, session experts will review the understanding of the adaptive immune response to SARS-CoV-2 and how this has shaped clinical practice, public health decisions, and vaccine studies. Three presentations will explore basic immunology, clinical assessment, and serological and functional assays. Another session will focus on the implementation of serological and molecular tools for COVID-19 patient management, and discuss the findings of the GENCOV study which links serological, genomic, viral and patient characteristics (sex, age, ancestry, symptom severity, comorbidities) to provide a comprehensive understanding of factors that contribute to variability in clinical symptoms and outcomes among COVID-19 patients.

The Population Health and Equity pathway will feature scientific sessions on strategies for enhancement of laboratory medicine in Africa, as well as on emerging areas in therapeutic drug monitoring: antifungals, direct oral anticoagulants, and psychoactive drugs.

The Molecular Medicine Pathway will feature session experts who will introduce key laboratory aspects of next generation sequencing for laboratorians, including technology, QC practices, and bioinformatics. Applications for hereditary and oncology testing will be discussed, including technology-based limitations and advantages. Another scientific session will introduce the recently published ASCCP “Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors” and “Cervical Cancer Screening for Individuals at Average Risk: 2020 Guideline Update” from ACS. Based on these guidelines, session experts will present contemporary research and recommendations for HPV testing. Speakers willalso explore the rapidly expanding scope of disorders detectable in newborn screening including X-linked adrenoleukodystrophy, adrenoleukodystrophy, and guanidinoacetate methyltransferase deficiency.

Related Links:
American Association for Clinical Chemistry


New
Gold Member
Hematology Analyzer
Medonic M32B
Serological Pipet Controller
PIPETBOY GENIUS
New
Human Estradiol Assay
Human Estradiol CLIA Kit
New
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)
ADLM

Channels

Molecular Diagnostics

view channel
Image: A diagnostic test can distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone (Photo courtesy of University of Turku)

Novel Diagnostic Tool to Revolutionize Treatment Guidance of Head and Neck Cancer

Head and neck squamous cell carcinoma (HNSCC) is a solid tumor type commonly treated with surgery. However, there has been no clinically available method to determine which patients can be cured with surgery... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.